No Prescription |
 |
 | ||
|
Pilocar Akarpine |
|
| ||
No Prescription » Prescription Drugs 13 » Pilocar Akarpine Pilocarpine is used to treat glaucoma a condition in which increased pressure in the eye can lead to gradual loss of vision. Pilocarpine relieves the symptoms of glaucoma.Pilocarpine comes in eyedrops eye gel and a controlled-release system (Ocusert Pilo). The eyedrops usually are applied two to four times daily. The gel usually is applied once daily and at bedtime. The controlled-release system is used once a week and should be applied at bedtime. Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. Use pilocarpine exactly as directed. Do not use more or less of it or use it more often than prescribed by your doctor.Pilocarpine controls glaucoma but does not cure it. Continue to use pilocarpine even if you feel well. Do not stop using pilocarpine without talking to your doctor.To use the eyedrops follow these steps: Wash your hands thoroughly with soap and water. Use a mirror or have someone else put the drops in your eye. Remove the protective cap. Make sure that the end of the dropper is not chipped or cracked. Avoid touching the dropper tip against your eye or anything else. Hold the dropper tip down at all times to prevent drops from flowing back into the bottle and contaminating the remaining contents. Lie down or tilt your head back. Holding the bottle between your thumb and index finger place the dropper tip as near as possible to your eyelid without touching it. Brace the remaining fingers of that hand against your cheek or nose. With the index finger of your other hand pull the lower lid of the eye down to form a pocket. Drop the prescribed number of drops into the pocket made by the lower lid and the eye. Placing drops on the surface of the eyeball can cause stinging. Close your eye and press lightly against the lower lid with your finger for 2-3 minutes to keep the medication in the eye. Do not blink. Replace and tighten the cap right away. Do not wipe or rinse it off. Wipe off any excess liquid from your cheek with a clean tissue. Wash your hands again. Buy Pilocar Akarpine and other Prescription Drugs 13 products online at Medstore. Buy Online at Medstore - Click Here!
About Pilocar Akarpine: Product Type: Prescription Drugs 13 Pilocar ( Akarpine Isopto Carpine Piloptic-1 Generic Pilocarpine ) Pilocar (Akarpine Isopto Carpine Piloptic-1 Generic Pilocarpine) Akarpine Isopto Carpine Piloptic-1 Generic Pilocarpine 2% w/v 5mL Eye Drops 2% w/v 6 x 5mL Eye Drops 2% w/v 3 x 5mL Eye Drops 4% w/v 5mL Eye Drops 4% w/v 3 x 5mL Eye Drops 4% w/v 6 x 5mL Eye Drops Akarpine Isopto Carpine Piloptic-1 Generic Pilocarpine Pilocar
View more Prescription Drugs 13 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
